摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,6-bis-(2′-pyrimidyl)-1,2,4,5-tetrazine | 161298-54-0

中文名称
——
中文别名
——
英文名称
3,6-bis-(2′-pyrimidyl)-1,2,4,5-tetrazine
英文别名
3,6-bis(2’-pyrimidyl)-1,2,4,5-tetrazine;3,6-bis(2-pyrimidinyl)-1,2,4,5-tetrazine;3,6-di(pyrimidin-2-yl)-1,2,4,5-tetrazine;3,6-Bis(2'-pyrimidyl)-1,2,4,5-tetrazine;3,6-bis(2-pyrimidyl)-1,2,4,5-tetrazine;3,6-di-2-pyrimidinyl-1,2,4,5-tetrazine
3,6-bis-(2′-pyrimidyl)-1,2,4,5-tetrazine化学式
CAS
161298-54-0
化学式
C10H6N8
mdl
——
分子量
238.211
InChiKey
XHPSGHROEWESJM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    274-277 °C
  • 沸点:
    605.3±38.0 °C(Predicted)
  • 密度:
    1.436±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -1.4
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    103
  • 氢给体数:
    0
  • 氢受体数:
    8

反应信息

  • 作为反应物:
    描述:
    3,6-bis-(2′-pyrimidyl)-1,2,4,5-tetrazine氘代丙酮二甲基亚砜 为溶剂, 生成 [(silver(I))2(2,5-di-tert-butyl-7,10-di(pyrimidin-2-yl)-8,9-diazafluoranthene)2](SbF6)2
    参考文献:
    名称:
    Cu(i) and Ag(i) complexes of 7,10-bis-N-heterocycle-diazafluoranthenes: programmed molecular grids?
    摘要:
    7,10-二取代二氮杂芴衍生物与三种不同的银离子(AgX,其中X = [PF6]-、[SbF6]-、[CB11HCl11]-)和[Cu(CH3CN)4]PF6反应,形成了展现出五种不同图案的配合物。
    DOI:
    10.1039/c4dt01460j
  • 作为产物:
    描述:
    2-氰基嘧啶盐酸 、 hydrazine hydrate 、 硝酸 作用下, 以 四氢呋喃N,N-二甲基甲酰胺 为溶剂, 反应 4.5h, 以68%的产率得到3,6-bis-(2′-pyrimidyl)-1,2,4,5-tetrazine
    参考文献:
    名称:
    通过空气稳定的基于四嗪的自由基阴离子介导的{Ni II 4 }团簇中的强铁磁交换耦合
    摘要:
    平面四齿3,6-双(2-嘧啶基)-1,2,4,5-四嗪(BpymTz)模板螯合物提供了前所未有的BpymTz + -自由基阴离子桥联的{Ni II 4 }络合物的形成。详述磁测量上的分离的空气中稳定进行[镍II 4(BpymTz˙ - )氯6(DMF)8 ]·氯0.5(H 2 O)化合物揭示强铁磁镍II -BpymTz˙ -相互作用与耦合常数Ĵ = 98.84cm -1。
    DOI:
    10.1039/c7cc04554a
点击查看最新优质反应信息

文献信息

  • Complexes of [Re(CO)3Cl] with different oxidation states of the polyfunctional bmtz/H2bmtz ligand system (bmtz=3,6-bis(2-pyrimidyl)-1,2,4,5-tetrazine)
    作者:Stéphanie Frantz、Wolfgang Kaim、Jan Fiedler、Carole Duboc
    DOI:10.1016/j.ica.2004.03.056
    日期:2004.9
    Abstract Combining fac -[Re(CO) 3 Cl] with components of the ligand redox system bmtz/bmtz − /H 2 bmtz/H 2 bmtz − (bmtz=3,6-bis(2-pyrimidyl)-1,2,4,5-tetrazine) has led to the isolation of the complexes (H 2 bmtz)Re(CO) 3 Cl, (μ-H 2 bmtz)[Re(CO) 3 Cl] 2 and (μ-bmtz)[Re(CO) 3 Cl] 2 . Other species characterized were (bmtz)Re(CO) 3 Cl (UV/Vis, IR), [(H 2 bmtz)Re(CO) 3 Cl] − (UV/Vis, IR, EPR), (μ-H 2
    摘要将fac-[Re(CO)3 Cl]与配体氧化还原体系的组分bmtz / bmtz-/ H 2 bmtz / H 2 bmtz-(bmtz = 3,6-bis(2-pyrimidyl)-1,2, 4,5-四嗪)导致了复合物(H 2 bmtz)Re(CO)3 Cl,(μ-H2 bmtz)[Re(CO)3 Cl] 2和(μ-bmtz)[Re (CO)3 Cl] 2。表征的其他物种是(bmtz)Re(CO)3 Cl(UV / Vis,IR),[(H 2 bmtz)Re(CO)3 Cl]-(UV / Vis,IR,EPR),(μ-H 2 bmtz)[Re(CO)3 Cl] 2}-(UV / Vis,IR,EPR)和(μ-bmtz)[Re(CO)3 Cl] 2}--(UV / Vis,IR,X band和高场EPR)。结果证实与一个或两个螯合键合的低价金属中心相比,bmtz非常强而H 2 bm
  • PDO OR BMTZ LIGAND FOR SUPPORTED COORDINATED PT HYDROSILYLATION CATALYSTS
    申请人:THE TRUSTEES OF INDIANA UNIVERSITY
    公开号:US20210069687A1
    公开(公告)日:2021-03-11
    The invention describes single-site metal catalysts such as Pt single-site centers on powdered oxide supports with a 1,10-phenanthroline-5,6-dione (PDO) or bis-pyrimidyltetrazine (BMTZ) ligand on powdered MgO, Al 2 O 3 , or CeO 2 .
    该发明描述了单位金属催化剂,如Pt单位金属中心在氧化物粉末载体上,带有1,10-邻菲啰啉-5,6-二酮(PDO)或双吡啶基四嗪(BMTZ)配体,分别载于氧化镁、氧化铝或氧化铈粉末上。
  • ADDITIVE FOR IMPARTING LOW HEAT BUILD-UP TO RUBBER COMPONENT
    申请人:OTSUKA CHEMICAL CO., LTD.
    公开号:US20200231782A1
    公开(公告)日:2020-07-23
    Provided is an additive for imparting low heat build-up to a rubber component, wherein the additive includes a tetrazine compound represented by general formula (1): (wherein X 1 and X 2 are the same or different and represent a hydrogen atom or an alkyl, alkylthio, aralkyl, aryl, arylthio, heterocyclic, or amino group; and each of these groups may have one or more substituents), or a salt thereof.
    提供一种用于给橡胶组件赋予低热积聚的添加剂,该添加剂包括一种由通式(1)表示的四唑化合物:(其中X1和X2相同或不同,代表氢原子或烷基、烷硫基、芳基、芳基硫基、杂环基或氨基;这些基团中的每一个可能有一个或多个取代基),或其盐。
  • 테트라진 기반 추진제용 아졸계 이온성 물질 및 이의 제조 방법
    申请人:AGENCY FOR DEFENSE DEVELOPMENT 국방과학연구소(319980058262) BRN ▼314-83-03869
    公开号:KR20210094851A
    公开(公告)日:2021-07-30
    본 발명은 테트라진 기반의 추진제용 아졸계 이온성 물질 및 이의 제조방법에 관한 것으로, 상세하게는 테트리진을 기반으로 1종 또는 2종의 아졸계 양이온이 서로 연결된 형태의 테트라진 기반의 아졸계 양이온을 포함하여 높은 둔감성을 가지는 것을 특징으로 하는 아졸계 이온성 물질이며, 테트라진 기반의 아졸계 양이온에서 아졸계 고리의 치환기를 나이트로화하거나, 본 발명의 테트라진 기반 추진제용 아졸계 이온성 물질의 음이온을 할로겐 이온을 포함한 다양한 음이온들로 치환을 통해 연소 속도를 조절하여 높은 폭발 열과 반응 특성을 지니는 테트라진 기반의 추진제용 아졸계 이온성 물질 및 이의 제조방법에 관한 것이다.
    本发明涉及以四氮唑为基础的推进剂用偶氮类离子性物质及其制备方法,具体包括以四氮唑为基础,包含一种或两种偶氮类阳离子相互连接的形式的四氮唑基偶氮类阳离子,具有较高的不敏感性的偶氮类离子性物质,其中通过将四氮唑基偶氮类阳离子中偶氮环的取代基硝化,或者通过用含卤离子的各种阴离子替换来调节燃烧速度,具有高爆热和反应特性的基于四氮唑的推进剂用偶氮类离子性物质及其制备方法。
  • Anion-induced Ag<sup>I</sup>self-assemblies with electron deficient aromatic ligands: anion–π-system interactions as a driving force for templated coordination networks
    作者:Damir A. Safin、Amélie Pialat、Alicea A. Leitch、Nikolay A. Tumanov、Ilia Korobkov、Yaroslav Filinchuk、Jaclyn L. Brusso、Muralee Murugesu
    DOI:10.1039/c5cc01597a
    日期:——

    1D, 2D and 3D AgIcoordination polymers were isolated using nitrogen based 3,6-bis(2′-pyrimidyl)-1,2,4,5-tetrazine and 2,4,6-tris(2-pyrimidyl)-1,3,5-triazine ligands.

    使用基于氮的3,6-双(2'-嘧啶基)-1,2,4,5-四嗪和2,4,6-三(2-嘧啶基)-1,3,5-三嗪配体分离出1D、2D和3D Ag配位聚合物。
查看更多

同类化合物

酸四嗪 甲四嗪-氨基叔丁酯 四嗪-氨基叔丁酯 嘧啶并[4,5-e]-1,2,3,4-四嗪 二甲基-1,2,4,5-四嗪 二氯均四嗪 METHYLTETRAZINE-ACID,甲基四嗪-羧基 6-苯基-1,2,4,5-四嗪-3-胺 6-乙基-1,2,4,5-四嗪-3-胺 6-丁基氨基-3-(3,5-二甲基吡唑-1-基)四嗪 6-(3,5-二甲基吡唑-1-基)-1,2,4,5-四嗪-3-胺 3,6-二苯基-1,2,4,5-四嗪 3,6-二氨基-1,2-二氢-1,2,4,5-四嗪盐酸盐 3,6-二-4-吡啶基-1,2,4,5-四嗪 3,6-二-2-吡啶基-1,2,4,5-四嗪 3,6-二(噻吩-2-基)-1,2,4,5-四嗪 3,6-二(3-吡啶基)-1,2,4,5-四氮杂苯 3,6-二(3,5-二甲基-1H-吡唑-1-基)-1,2,4,5-四嗪 1-[6-(3,5-二甲基吡唑-1-基)-1,2,4,5-四嗪-3-基]-2-(丙-2-亚基)肼 1,2-二氢-1,2,4,5-四嗪-3,6-二酮 1,2,4,5]四嗪-3,6-二羧酸 1,2,4,5-四嗪-3-胺 1,2,4,5-四嗪-3,6-二羧酸二甲酯 1,2,4,5-四嗪 (9CI)-吡咯并[2,1-d]-1,2,3,5-四嗪 (6-肼基-1,2,4,5-四嗪-3-基)肼 3-(3,5-Dimethyl-1-pyrazolyl)-6-(2-trifluoroacetylhydrazino)-1,2,4,5-tetrazine 3-cyclohexyl-6-(3,5-dimethyl-1H-pyrazol-1-yl)[1,2,4]triazolo[4,3-b][1,2,4,5]tetrazine 3-ethyl-6-(3,5-dimethyl-1H-pyrazol-1-yl)[1,2,4]triazolo[4,3-b][1,2,4,5]tetrazine 6-pentyl-6-(3,5-dimethyl-1H-pyrazol-1-yl)[1,2,4]triazolo[4,3-b][1,2,4,5]tetrazine 3-benzyl-6-(3,5-dimethyl-1H-pyrazol-1-yl)[1,2,4]triazolo[4,3-b][1,2,4,5]tetrazine 3-methyl-6-(3,5-dimethyl-1H-pyrazol-1-yl)[1,2,4]triazolo[4,3-b][1,2,4,5]tetrazine N'-(6-(3,5-dimethyl-1H-pyrazol-1-yl)-1,2,4,5-tetrazin-3-yl)propionohydrazide 3-(2-ethylidenehydrazinyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-1,2,4,5-tetrazine (1,2,4,5-tetrazine-3,6-diyl)dimethanol 3-amino-6-chloro-1,2,4,5-tetrazine 6-(3,5-dimethyl-1H-pyrazol-1-yl)-N-methyl-1,2,4,5-tetrazin-3-amine N-(tert-butyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-1,2,4,5-tetrazin-3-amine 6-(3,5-dimethyl-1H-pyrazol-1-yl)-N-(prop-2-en-1-yl)-1,2,4,5-tetrazin-3-amine 3-(2-pyrimidyl)-6-(2-hydroxy)ethyl-1,2,4,5-tetrazine 3-isopropyl-6-phenyl-1,2,4,5-tetrazine 6-butylamino-3-chlorotetrazine 3,6-di(1H-pyrazol-4-yl)-1,2,4,5-tetrazine N-(1H-tetrazol-5-yl)-1,2,4,5-tetrazin-3-amine 3-(3,5-dimethylpyrazolyl)-6-[tris(hydroxylmethyl)aminomethane]-1,2,4,5-tetrazine 2-([1,2,4]triazolo[4,3-b][1,2,4,5]tetrazin-3-ylamino)-2-(hydroxymethyl)propane-1,3-diol 6-amino-1,2,4-triazolo<4,3-b><1,2,4,5>tetrazine N-phenethyl-[1,2,4]triazolo[4,3-b][1,2,4,5]tetrazin-3-amine 2,5-dioxopyrrolidin-1-yl 2-(4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl)acetate furazano-1,2,3,4-tetrazine 1,3-dioxide